Welcome to our dedicated page for Selectis Health news (Ticker: GBCS), a resource for investors and traders seeking the latest updates and insights on Selectis Health stock.
Selectis Health Inc. operates as a public healthcare company focused on healthcare facilities that provide living services, speech, occupational and physical therapies, social services, rehabilitation and related healthcare services. The company has described its facility footprint across Arkansas, Georgia, Ohio and Oklahoma, with an emphasis on care settings serving aging populations.
Recurring developments for GBCS include skilled nursing facility portfolio changes, completed asset sales, material agreements, capital-structure updates, shareholder voting matters and operating and financial results. Company announcements also cover governance changes, including board and executive appointments, as well as healthcare regulatory disclosure topics tied to its facility operations.
Selectis Health (OTCQB: GBCS) has become the target of a cash tender offer launched by New York-based investment group Black Pearl Equities to acquire all outstanding Selectis common shares at $5.75 per share, pursuant to a June 22, 2026 Agreement and Plan of Merger.
The tender offer expires at 5:00 p.m. New York City time on August 10, 2026, unless extended, and is conditioned on at least 70% of outstanding shares being validly tendered, receipt of required regulatory approvals, and other customary closing conditions. The transaction is not subject to financing contingencies.
Following successful completion of the tender offer, Black Pearl plans a short-form merger of a wholly owned subsidiary into Selectis under Utah law, cashing out remaining shares at $5.75 per share (with limited exceptions). Selectis’ board has unanimously recommended that stockholders accept the tender offer. Laurel Hill Advisory Group is the information agent, and Broadridge Corporate Issuer Solutions is the depositary.
Black Pearl Equities has commenced a cash tender offer to acquire all outstanding shares of Selectis Health (OTCQB: GBCS) at $5.75 per share, under a June 22, 2026 Agreement and Plan of Merger between Black Pearl affiliates and Selectis.
The offer expires at 5:00 p.m. New York City time on August 10, 2026, unless extended. Closing conditions include at least 70% of outstanding shares being validly tendered, required regulatory approvals, and other customary conditions, with no financing contingency disclosed.
After the tender, Black Pearl plans a short-form merger under Utah law, cashing out remaining shares at $5.75 per share, without interest and subject to tax withholding. Selectis’ board unanimously recommends shareholders accept the offer. Laurel Hill Advisory Group is information agent and Broadridge Corporate Issuer Solutions is depositary.
Selectis Health (OTCQB:GBCS) agreed to be acquired by affiliates of Black Pearl Equities for $5.75 per share in cash via a tender offer.
Black Pearl will launch the offer within ten business days. Closing is targeted for Q3 2026, requiring at least 70% of shares tendered, regulatory approvals, and other customary conditions. The board unanimously approved the deal, which has no financing contingency and will be followed by a short-form merger under Utah law.
Black Pearl Equities has commenced a cash tender offer to buy up to 100% of Selectis Health (OTCQB: GBCS) at $5.05 per share, representing a 45% premium to the trading price as of March 11, 2026. The offer expires at 5:00 p.m. ET on May 11, 2026, unless extended.
The transaction is subject to conditions including a minimum 51% tender, absence of a material adverse change, and customary closing conditions. The Selectis Health board has not yet responded. Shareholders should review the Schedule TO and Offer to Purchase and may contact D.F. King & Co. at (800) 769-4414 for assistance.
Selectis Health (OTC: GBCS) completed the sale of two Georgia skilled nursing properties—Providence of Sparta Health & Rehab and Warrenton Health & Rehabilitation—for an aggregate purchase price of $13,175,000, effective January 15, 2026. After payment of senior mortgages, transaction costs and a $1.3 million holdback, the company derived approximately $5.4 million in net proceeds.
From those proceeds Selectis paid $475,000 to settle title issues, $1.8 million to redeem senior secured notes, $700,000 to reduce capital lines of credit used for accrued bed taxes, and $700,000 to retire a mortgage on another facility; the remaining balance will be used for general working capital. Selectis will continue to own and operate several remaining facilities, including two in Georgia.
Selectis Health (OTC:GBCS) entered a definitive Purchase and Sale Agreement to sell two Georgia skilled nursing properties — Providence of Sparta and Warrenton Health & Rehabilitation — for $13,175,000, subject to customary prorations, holdbacks and adjustments. The target closing date is February 1, 2026. Post-transaction Selectis will continue to operate remaining facilities including Eastman and Glen Eagle in Georgia.
2025 highlights cited include $1,484,703.19 of Georgia bed taxes paid down, occupancy gains at Southern Hills (from 55–61% to 68–71%), Park Place census growth (from 48 to 65 patients and skilled patients from 1 to 10), and an upgrade to the OTCQB in June 2025.
Selectis Health (OTC: GBCS) has permanently appointed Adam Desmond as Chief Executive Officer, effective October 17, 2024. The Board of Directors has approved a salary increase for Desmond from $150,000 to $250,000 per annum. In exchange, Desmond has agreed to forgo the Company's Board Compensation stipend of $7,500 quarterly.
Desmond, who has been serving as Interim CEO since October 22, 2022, has demonstrated strong leadership over the past two years by navigating the company through challenging market conditions and focusing on long-term strategic goals. These include improving operational efficiencies, divesting non-core assets, and strengthening the balance sheet.
CFO Jim Creamer expressed confidence in Desmond's ability to advance strategic initiatives, guide the company forward, and build long-term shareholder value.
Selectis Health (OTC: GBCS) has completed the sale of the Archway Transitional Care Center in Macon, Georgia, for $6.75 million. The transaction, closed on June 18, 2024, was executed by the company's subsidiary, Goodwill Hunting, , to Bibb County Holdings II, The sale includes the real estate, buildings, and certain personal property associated with the facility. CEO Adam Desmond stated that the sale aligns with the company's operational improvement initiatives and aims to enhance its balance sheet, retire existing debt, and optimize its remaining facility footprint. Selectis Health will continue to operate other facilities in Georgia and other states, maintaining a significant presence in the skilled nursing and healthcare sectors.
Selectis Health, Inc. (OTC: GBCS) has entered into a definitive Purchase and Sale Agreement to sell Archway Transitional Care Center in Georgia for $6.75 million. The transaction is expected to enhance the company's balance sheet and provide flexibility for further initiatives. The sale includes certain real property in Macon, Bibb County, Georgia, with the Purchaser having a 45-day Inspection Period. Upon completion of the sale, Selectis Health will continue to own and operate various healthcare facilities in Georgia and other states.
Summary not available.